Articles related to MEDICAL UNIVERSITY PRESS
Dana-Farber Study Finds Up-front Chemotherapy Boost Could Benefit Patients with Non-Small Cell Lung Cancer
Discover how the FLAURA2 trial’s findings on combination therapy could revolutionize initial treatment plans for NSCLC patients with EGFR mutations. Learn more about the significant extension in progression-free survival and its potential clinical implications.
Oncology, Medical September 25th 2023
Roswell Park Clinical Trials Add Beta Blocker to Arsenal Against Esophageal Cancer
Discover how Roswell Park’s phase 2 clinical trials are exploring the potential of propranolol to enhance the efficacy of immunotherapies in treating esophageal cancer. This could represent a significant shift in treatment protocols.
Oncology, Medical September 19th 2023
Final Overall Study Analysis Continues to Show Benefit of Sacituzumab Govitecan in Advanced HR+ Breast Cancer
Discover how sacituzumab govitecan is setting a new standard in the treatment of HR+, HER2- metastatic breast cancer, offering improved survival rates and lower risks of progression.
Obstetrics & Gynecology September 11th 2023
Dana-Farber AI-Model Predicts Primary Source of Cancer Using Gene Sequencing Data
Explore the potential of OncoNPC, an AI model that leverages gene sequencing data to predict the primary source of cancer, offering a new avenue for more targeted and effective treatments.
Hematology/Oncology August 29th 2023
Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health
The Icahn School of Medicine at Mount Sinai has launched a pioneering center dedicated to the advancement of AI in ophthalmology. This initiative aims to transform patient care and research, focusing on early detection and intervention of various eye diseases and related systemic conditions.
Ophthalmology August 23rd 2023
New Therapeutic Target for Parkinson’s Disease Discovered
Northwestern Medicine’s recent study uncovers a novel interaction between lysosomes and mitochondria, disrupted by mutations in the parkin gene, contributing to Parkinson’s disease. This discovery offers a new therapeutic pathway and emphasizes the significance of organelle communication in neurodegenerative disorders.
Neurology August 22nd 2023